FEED ENvue Medical, Inc
$0.35▲ +37.94%
Healthcare
Other
Volume 1
Avg Volume (10D) 18.0K
Key Metrics & Fundamentals
Market Cap
$318,682
P/E Ratio
–
Div Yield
0.00%
52W Range
0.12 - 73.08
% vs 50 MA
-81.97%
% vs 200 MA
-97.26%
RSI-14
34.9
MACD Histogram
+0.1100
Beta (1Y vs SPY)
0.98
Free Cash Flow
-$2.72M
Gross Rev
$239,000
Gross Profit
-$266,000
EBITDA
-$4.65M
COGS
$505,000
Operating Exp
$5.21M
Operating Income
-$5.47M
EBIT
-$5.47M
Pretax Income
-$4.90M
Net Income
-$4.90M
EPS (Diluted)
-1.98
Price & Volume History
Loading chart…
Recent News
ENvue Medical Issues Letter to Shareholders
ACCESS Newswire · Oct 26, 2026 7:30 AM ET
ENvue Medical Provides Nasdaq Listing Update
GlobeNewswire · Sep 15, 2026 12:45 PM ET
ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor Orders
GlobeNewswire · Sep 9, 2026 8:30 AM ET
ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange
GlobeNewswire · Sep 2, 2026 8:30 AM ET
ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split
GlobeNewswire · Aug 28, 2026 8:00 AM ET
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
GlobeNewswire · Aug 18, 2026 8:30 AM ET
ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions
GlobeNewswire · Aug 12, 2026 8:35 AM ET
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
GlobeNewswire · Aug 4, 2026 9:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See FEED's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.